Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Serra-Baldrich
Omalizumab Updosing Allows Disease Activity Control in Refractory Patients With Chronic Spontaneous Urticaria
British Journal of Dermatology
Dermatology
Medicine
Related publications
Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
Bőrgyógyászati és Venerológiai Szemle
Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
Frontiers in Immunology
Allergy
Immunology
Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab
European Annals of Allergy and Clinical Immunology
Allergy
Immunology
Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria
Asim, Allerji, Immunoloji
Respiratory Medicine
Pulmonary
Allergy
Immunology
Treatment Refractory Chronic Spontaneous Urticaria Patients Achieves Remission With Low Molecular Weight Heparin
Journal of Allergy and Clinical Immunology
Allergy
Immunology
The Efficacy of Omalizumab Therapy in Chronic Spontaneous Urticaria: A Retrospective Analysis
Turkderm Deri Hastaliklari ve Frengi Arsivi
Dermatology
Infectious Diseases
Omalizumab in Chronic Urticaria: A Comprehensive Review
Turkderm Deri Hastaliklari ve Frengi Arsivi
Dermatology
Infectious Diseases
Strategies for Discontinuing Omalizumab in Patients With Chronic Urticaria: Real-World Findings
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Clinical Management of Urticaria Using Omalizumab: The First Licensed Biological Therapy Available for Chronic Spontaneous Urticaria
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases